Topics

GILD Seeks To Revoke Coveted Status, ELOX Pauses Trial, PRQR On Watch

01:49 EDT 26 Mar 2020 | RTTNews

Today's Daily Dose brings you news about Immutep's breast cancer trial results, ProQR Therapeutics' near-term catalyst, Eloxx Pharma pausing patient enrolment in its cystic fibrosis trial due to COVID-19 pandemic, Jazz Pharma's regulatory catalyst and Gilead seeking to revoke the coveted status for potential COVID-19 drug.

Original Article: GILD Seeks To Revoke Coveted Status, ELOX Pauses Trial, PRQR On Watch

NEXT ARTICLE

More From BioPortfolio on "GILD Seeks To Revoke Coveted Status, ELOX Pauses Trial, PRQR On Watch"

Quick Search